23 /100
LOW RISK
Score updated May 30, 2026

NYMXF — Nymox Pharmaceutical Corporation Dilution Risk Tracker

Track NYMXF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NYMXF — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.07 below $1 exchange minimum
🔔 Track NYMXF — Get forecast alerts →

💹 Market Data

Market Cap$13.47M
Shares Outstanding94.54M
Float54.97M
Cash$74.0K
Debt$3.29M
Short InterestN/A

🏛 Institutional Holdings

0.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track NYMXF for full holder detail →

📉 Short Interest

Short Interest5.3K
Days to Cover1.0
% of Float0.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track NYMXF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NYMXF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for NYMXF
📊 NYMXF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NYMXF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.